Terms of Reference

Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013

Terms of Reference

Reasons for referral/principal issues for consideration:

To receive evidence on the need for regulation of pharmaceutical industry conduct with regards to interactions with the medical profession, and the appropriateness of the provisions in the bill that place restrictions on these interactions.


For further information, contact:

Senate Finance and Public Administration Committees
PO Box 6100
Parliament House
Canberra ACT 2600
Australia

Phone:+61 2 6277 3439
Fax:+61 2 6277 5809
Email:fpa.sen@aph.gov.au

Facebook LinkedIn Twitter Add | Email Print
Back to top